EXAS vs NRIM · rev $2.76B vs P/E 13, rev $123.7M
EXACT Sciences Corporation (EXAS) versus Northrim BanCorp Inc (NRIM) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Northrim BanCorp Inc (NRIM) is a banks - regional company listed on US.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported NRIM revenue for 2026-06-30 was $123.7M. Net income was $29.0M. NRIM currently screens at market cap $522.9M and trailing P/E 12.6.
EXAS currently screens at market cap $20.03B. NRIM currently screens at market cap $522.9M and trailing P/E 12.6.
Not investment advice. Open the EXAS and NRIM stock pages for the full models.
Not investment advice.